Prakriti Roy

Protocol for ICiCLe-ALL-14 (InPOG-ALL-15-01): a prospective, risk stratified, randomised, multicentre, open label, controlled therapeutic trial for newly diagnosed childhood acute lymphoblastic leukaemia in India

Nandana Das, Shripad Banavali, Sameer Bakhshi et al. · Trials · 2022 · 81 citations · Full text

Medicine, Hematology, Pediatrics +17

Characteristics and outcome of children with renal tumors in the Netherlands: The first five-year’s experience of national centralization

Prakriti Roy, Sophie E. van Peer, Martin M. de Witte et al. · PLoS ONE · 2022 · 29 citations · Full text

Medicine, Oncology, Pediatrics +12

Unsatisfactory quality of <i>E. coli</i> asparaginase biogenerics in India: Implications for clinical outcomes in acute lymphoblastic leukaemia

Jasmeet Sidhu, Manash Pratim Gogoi, Praveen Agarwal et al. · Pediatric Blood & Cancer · 2021 · 27 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Efficacy and safety of a bortezomib and reduced‐intensity cytarabine‐based protocol, TMC ALLR1, for relapsed childhood ALL in India

Prakriti Roy, Rubina Islam, Debparna Saha et al. · British Journal of Haematology · 2019 · 15 citations · Full text

Medicine, Oncology, Pediatrics +16

Locoregional control using highly conformal flank target volumes and volumetric-modulated arc therapy in pediatric renal tumors: Results from the Dutch national cohort

Joeri Mul, Martine van Grotel, Enrica Seravalli et al. · Radiotherapy and Oncology · 2021 · 15 citations · Full text

Medicine, Oncology, Radiation Oncology +17